Researchers from the National Institutes of Health (NIH) are applying artificial intelligence to the recruitment of ...

(TSX: CRDL) has seen success under a phase II trial conducted on CardiolRx, which is the company’s lead small molecule drug ...

Q3 2024 Earnings Call Transcript November 18, 2024 Operator: Good afternoon, ladies and gentlemen, and welcome to the NRx ...

The $1.2 billion company has some of the biggest podcast bros and athletes touting its praises. Is the greens powder the ...

Researchers from the National Institutes of Health (NIH) have developed an artificial intelligence (AI) algorithm to help speed up the process of matching potential volunteers to relevant clinical ...

Amlodipine & perindopril, amlodipine & indapamide, and perindopril & indapamide achieved blood pressure control in 70 percent ...

A peptide hormone produced in the brain that triggers physiological reproductive responses has been 'hacked' by scientists to form an effective, safe and non-invasive way to treat chronic gut pain. It ...

The pathology and radiology giant is recovering from its post-pandemic malaise and says earnings should improve this year ...

Atrial fibrillation, or Afib, is the most common type of heart arrhythmia. Afib increases your risk of heart attack and ...

A year ago, there was 1 drug for idiopathic pulmonary fibrosis in trials at Temple Health. Now there are 10 active trials and 8 more coming up.

Eli Lilly said the treatment, a once-daily pill called muvalaplin, showed reductions in Lp (a) levels compared to placebo. Injectables are currently in Phase 3 development, but "these are the first ...